Cystic Fibrosis Clinical Trial
Official title:
A Case Series Examining the Impact of a Positive Parenting Program (Self Directed Teen Triple P) on Treatment Adherence in Families With an Adolescent With Cystic Fibrosis
| Verified date | October 2016 |
| Source | University of Manchester |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: Research Ethics Committee |
| Study type | Interventional |
Cystic fibrosis (CF) is an illness that makes the lungs clog up with sticky mucus. There is no cure and so treatments are used to help make the illness easier to live with. The treatment can take lots of time and can feel not very nice sometimes. When children with CF become teenagers they need to learn to take charge of their treatment. This can be difficult. Teenagers with CF want to fit in with friends and can become more upset about their illness. Their parents have to learn to let their child take charge of their illness which can be hard for parents. These issues can put strain on parent-child relationships and this can make it harder for teenagers to stick to their treatment plans. A parenting program (called Teen Triple P) has been shown to help teenagers with other illnesses (such as diabetes) to be able to stick to their treatment plans. Parents are given a booklet to work through at home which helps them to build on the skills they already have. It aims to help families to support positive parent-child relationships, to manage difficult teenage behaviours, and to teach new skills and behaviours. So far no one has done any research to see if this program helps families of teenagers with CF. This research would like to see if the Triple P program can help teenagers with CF stick to their treatment plan. Helping teenagers stick to their treatment plan will help them to live happier and healthier lives.
| Status | Completed |
| Enrollment | 6 |
| Est. completion date | June 2016 |
| Est. primary completion date | June 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Parents of adolescents (aged 11 to 16) with Cystic Fibrosis. - Self reported difficulties with their child's treatment adherence. Exclusion Criteria: - Families already receiving psychological support from specialist Cystic Fibrosis clinical psychologists - Parents requiring reading assistance who do not have anyone to help them - Families where the parent/ child is currently being treated for a mental health difficulty |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Emma Wells | Central Manchester University Hospitals NHS Foundation Trust |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Parent satisfaction with the intervention at mid and end intervention points as measured by Client Satisfaction Questionnaire | is designed to collect information to evaluate the different interventions and help to improve the Triple P programme. Administered only at post-intervention the questionnaire addresses the quality of the intervention, the extent to which it met the participant's needs, the effect it had on their parenting skills and child's behaviour problems. All items are measured on a 7 point Likert scale. | weeks 5 and 10 of intervention | No |
| Primary | Change in Treatment Adherence from baseline as measured by Treatment Adherence Questionnaire - Revised (Quittner et al., 2008) | consists of 12 items across four subscales corresponding to different domains of CF treatment regime. It asks about adherence to various elements of treatment in the last week. Answers are measured across a 6 point Likert scale ranging from "not at all" to "3 or more times a day". Internal consistency (a=.82-.84) and test-retest reliability (r's=.42-.57) have been examined. This measure takes a maximum of 5 minutes to complete. | baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up | No |
| Primary | Change in parenting skill and competence from baseline as measured by The Parenting Scale (PS; Arnold et al., 1993) | 30 item questionnaire measuring parent discipline styles. It has adequate internal consistency, good test-retest reliability and reliably distinguishes between clinical and non-clinical samples. This measure takes approximately 10 minutes to complete. | baseline, intervention weeks 1, 2,3,4,5,6,7,8,9,10, and 1 month follow up | No |
| Secondary | Change in parent stress from baseline as measured by Pediatric Inventory for Parents: PIP (Streisand et al., 2001) | This has 42 items that ask parents to describe the frequency and intensity with which they experience stress related to caring for their child's illness across four domains: (a) communication (b) emotional functioning (c) child's medical care and (d) role functioning. Parents indicate on a scale from 1 (never) to 5 (very often) how often an event had occurred in the past 7 days and how difficult each event was. Internal consistency for the PIP has been shown to be good for both scales, frequency: a = .94, difficulty: a = .96 | baseline,weeks 5 and 10 of intervention, and 1 month follow-up | No |
| Secondary | Change in parent's sense of competence from baseline as measured by Parent Sense of Competency Scale (PSOC; Gibaud-Wallston & Wandersman, 1978) | A 17 item measure assessing parental competence on two dimensions: satisfaction with the parenting role and feelings of efficacy as a parent. This also has good internal consistency and test-retest reliability. This measure takes approximately 5 minutes to complete | baseline,weeks 5 and 10 of intervention, and 1 month follow-up | No |
| Secondary | Change in child's emotional wellbeing and behavioural difficulties from baseline as measured by Strengths and Difficulties Questionnaire (SDQ: Goodman, 1997) | a brief behavioural screening questionnaire about 3-16 year olds. Parents are asked 25 questions about their child, which are divided between 5 subscales: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems and prosocial behaviour. Parents rate each item as "not true", "somewhat true", and "always true" of their child. This measure has very good psychometric properties and is used as a routine child wellbeing outcome measure in many child mental health teams in the UK. | baseline,weeks 5 and 10 of intervention, and 1 month follow-up | No |
| Secondary | Change in parent emotional wellbeing from baseline as measured by The Depression, Anxiety and Stress Scale - 21 item version (DASS-21) | a 21 item self-report Questionnaire designed to measure the severity of a range of symptoms common to both Depression and Anxiety. Parents rate their responses to each item on a 4 point Likert scale from "never" to "almost always". The reliability and validity of this measure is very good, with internal consistency and validity being scored in the acceptable to excellent ranges | baseline,weeks 5 and 10 of intervention, and 1 month follow-up | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |